SCID Mouse: Human Xenograft Core
SCID Mouse: Human Xenograft Core
批准号:
7608570
负责人:
JORDAN S POBER
金额:
$11.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2009-03-31
关键词:
AdultAllogenicAntibodiesAutologousB-LymphocytesBiopsyBlood CellsCellsDevelopmentElementsEndotheliumEngraftmentFamily suidaeFutureHematopoietic SystemHumanImmunodeficient MouseInfectious AgentInfectious Skin DiseasesInflammatoryLifeMethodsModelingMusMutant Strains MiceNeonatalNumbersPatientsPopulationPreparationResearch PersonnelSCID MiceSkinSkin graftSus scrofaT-LymphocyteTechniquesTechnologyThickTimeTrainingVariantWorkXenograft ModelXenograft procedurein vivomemberneutrophilnovelpenis foreskinresearch studyresponseskin disorderskin xenograftvascular bedvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The SCID mouse: The skin xenograft core has developed methods to routinely generate severe combined
immunodeficient (SCID) beige (bg) double mutant mice engrafted with human skin in the form of split thickness
skin grafts or with synthetic skin constructs incorporating human skin cells. The three specific aims of the
core are (1) to provide members of the YSDRC (both established and junior investigators, and especially
investigators with YSDRC P/F projects) with limited numbers of C.B-17 SCID/beige mice engrafted with
healthy adult human skin or skin constructs for establishing the utility of these models for specific skin
disease-related studies; (2) to train members of the YSDRC to generate such mice once feasibility has been
established; and (3) to develop variant models of this technique for new and novel applications, specifically
focusing on synthetic skin equivalents constructed from distinct populations of cells both from patients with
specific skin diseases and/or that may be genetically modified to alter biologic functions. The core will also
continue evaluating alternative mouse recipient strains and methods to combine human skin grafts with
elements of the human hematopoietic system to better model inflammatory skin disorders and responses to
skin infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium
-
批准号:10783379
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2023
-
负责人:JORDAN S POBER
-
依托单位:
Assessment of immunogenicity and antigenicity of different human cell types in natural and 3D-printed allografts
-
批准号:10353416
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2021
-
负责人:JORDAN S POBER
-
依托单位:
Assessment of immunogenicity and antigenicity of different human cell types in natural and 3D-printed allografts
-
批准号:10194232
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2021
-
负责人:JORDAN S POBER
-
依托单位:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium
-
批准号:10197784
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2017
-
负责人:JORDAN S POBER
-
依托单位:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium
-
批准号:10155842
-
项目类别:
-
资助金额:$2.94万
-
财政年份:2017
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:9516109
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2017
-
负责人:JORDAN S POBER
-
依托单位:
Targeting Nanoparticles for Drug Delivery to Renal Graft Endothelium during Ex Vivo Normothermic Perfusion
-
批准号:9164300
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2016
-
负责人:JORDAN S POBER
-
依托单位:
Bioengineered siRNA/Nanoparticles to Prevent Human Transplant Rejection
-
批准号:8693080
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2013
-
负责人:JORDAN S POBER
-
依托单位:
Spatiotemporal Delivery of miRNA Anatgomir for Promoting Vascular Self-Assembly
-
批准号:8322816
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2011
-
负责人:JORDAN S POBER
-
依托单位:
Controlled Spatiotemporal Delivery of miRNA Anatgomir for Promoting Vascular Self
-
批准号:8138278
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2011
-
负责人:JORDAN S POBER
-
依托单位:
SCID Mouse : Human Xenograft Core
-
批准号:7392297
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2007
-
负责人:JORDAN S POBER
-
依托单位:
Endothelial control of IFN-gamma and i-NOS in pathogenic T cells
-
批准号:7491181
-
项目类别:
-
资助金额:$42.78万
-
财政年份:2007
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:9102509
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:8657086
-
项目类别:
-
资助金额:$39.78万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:9335938
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:8529594
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Endothelial control of IFN-gamma and i-NOS in pathogenic T cells
-
批准号:7297613
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:9759975
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Administration
-
批准号:7297631
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
-
批准号:8296172
-
项目类别:
-
资助金额:$40.48万
-
财政年份:2006
-
负责人:JORDAN S POBER
-
依托单位:
海外基金